Senolytic ABT-263 Shows Promise in Mitigating Radiation-Induced Gastrointestinal Cancer
Recent studies at Georgetown University Medical Center have shown promising results regarding the use of the senolytic agent ABT-263 in ...
Recent studies at Georgetown University Medical Center have shown promising results regarding the use of the senolytic agent ABT-263 in ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine